1. Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
2. United Nations Office on Drugs and Crime/World Health Organization (NODC/WHO).Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality. Vienna: United Nations;2013. Available at: http://www.unodc.org/docs/treatment/overdose.pdf (accessed 28 October 2015). (Archived athttp://www.webcitation.org/6eKymocMnon 6 January 2016).
3. US Food and Drug Administration.FDA moves quickly to approve easy‐to‐use nasal spray to treat opioid overdose. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm (accessed 18 November2015). (Archived athttp://www.webcitation.org/6eKz6YZVOon 6 January 2016).
4. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans;Schuh K. J.,;J Pharmacol Exp Ther,1996